Fluorquinolone Legal News Articles & Interviews

Los Angeles, CA Bayer and Merck are facing a product liability lawsuit filed by a woman from Nebraska who alleges she developed peripheral neuropathy while on the popular antibiotic Avelox.

Washington, DC It’s little wonder the US Food and Drug Administration (FDA) is in the throes of taking a good hard look at fluoroquinolones (FQs) and their association with Peripheral Sensorimotor Neuropathy. An important Canadian study appearing in late September in the Journal Neurology has the medical community talking. With headlines screaming “FDA Evaluating Fluoroquinolone Antibiotics,” it’s no surprise that everyday consumers are talking too, given that antibiotics such as Levaquin and Cipro are oft-prescribed for a wide variety of serious infections.

Vancouver, BC A Canadian-US research team has made an important and scientifically proven link between a class of potent and commonly used antibiotics known as fluoroquinolones (FQs) and a condition known as peripheral neuropathy (PN).

Washington, DC The Food and Drug Administration (FDA) has issued notice that it requires the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs to be updated to better describe the serious side effect of peripheral neuropathy (PN). This serious nerve damage potentially caused by fluoroquinolones may occur soon after these drugs are taken and may be permanent.